MSCV-myc-CAR-2A-Thy1.1 Citations (3)

Originally described in: NR4A transcription factors limit CAR T cell function in solid tumours.
Chen J, Lopez-Moyado IF, Seo H, Lio CJ, Hempleman LJ, Sekiya T, Yoshimura A, Scott-Browne JP, Rao A Nature. 2019 Mar;567(7749):530-534. doi: 10.1038/s41586-019-0985-x. Epub 2019 Feb 27. PubMed Journal

---

Articles Citing MSCV-myc-CAR-2A-Thy1.1

Articles
TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy. Patel CH, Dong Y, Koleini N, Wang X, Dunkerly-Eyring BL, Wen J, Ranek MJ, Bartle LM, Henderson DB, Sagert J, Kass DA, Powell JD. JCI Insight. 2023 Nov 8;8(21):e167829. doi: 10.1172/jci.insight.167829. PubMed
The Nuclear Receptor NR1B1/RARalpha Arrests the Differentiation of Anti-Tumor Effector Cytotoxic T Cells. Niekamp P, Kim RH, Jayaraman A, Klement N, Kostlan R, Kim CH. Adv Sci (Weinh). 2025 May;12(17):e2410241. doi: 10.1002/advs.202410241. Epub 2025 Mar 11. PubMed
Aged circulating CD8(+) T cells and their secreted factors drive cognitive decline. Sucharov J, Bieri G, Pratt KJB, Philp AR, Aghayev T, Sahota S, Remesal L, Schroer AB, Snethlage CE, Chu R, Holmes ZJ, Couthouis J, Villeda SA. Immunity. 2026 Jun 9;59(6):1651-1666.e8. doi: 10.1016/j.immuni.2026.04.014. Epub 2026 May 14. PubMed

If you have published an article using this material, please email us at to have your article added to this page.